Foundation / Corporation
Worldwide Cancer Research
05/03/19 5:00 PM British Local Time
Grants to USA, Canada, and International researchers at nonprofit research institutions for innovative, novel, and potentially transformative research related to the biology of cancer. Funding is intended to support basic or translational research into the diagnosis, causes, mechanisms, treatment, or prevention of cancer. Funding decisions are made on the basis of scientific quality, innovation and the belief that the researchers can deliver on their ambitious proposals.
The goal of the program is to support research that seeks to answer the difficult questions in cancer biology. Funding is available for innovative and truly novel ideas that have the potential to revolutionize the understanding of cancer and how to beat it. The Fund does not prioritize any field of research within this; they welcome research that draws on epidemiological, behavioral and clinical data to provide a starting point for a new avenue of research. Multidisciplinary or discipline-hopping projects are encouraged where this helps stimulate innovation.
The research described in the application should be a discrete, hypothesis-driven project, achievable within the duration of the support requested. Do not describe a large program of work - for example the work of your entire laboratory - and then request a contribution towards it - for example funding one member of the laboratory or part of the consumable costs. Basic studies into fundamental cellular processes, mechanisms and molecules are within remit if it is clear that the aim of the research is to improve the understanding of cancer biology. If a project is to study the normal functioning of cellular processes, mechanisms or molecules - or to study very basic models such as yeast - evidence supporting the relevance to cancer biology must be laid out.
The Fund is looking for:
- Innovation and Creativity
- Focus and Novelty
- Transformative and Long Term
- Scientific Quality
For details on these criteria, see: https://www.worldwidecancerresearch.org/wp-content/uploads/2019/03/Worldwide-Cancer-Research-Grant-Application-Handbook-April-2019.pdf#page=3
Grants cover the direct costs of the project including research consumables and reagents, the salaries of research staff working directly on the project, travel to conferences or to visit collaborators, and any essential services or small pieces of specialist or unusual equipment. For additional information about allowable expenses, see:
GrantWatch ID#: 159227
The maximum budget allowed is £250,000, but it should be noted that most of the three-year grants awarded have a budget below £200,000.
Project grants are awarded from 12 to 36 months in length. Successful applications submitted to the April 2019 grant round will be offered a grant that can start from 1 February 2020.
The Fund may allow the start date to be deferred by up to 3 months providing prior approval has been sought. Delays in excess of 6 months will only be granted in exceptional circumstances.
Project grants are awarded to principal investigators based at any not-for-profit research institute in the world. The principal investigator must be a suitably qualified researcher (minimum of PhD followed by three years research experience, or equivalent qualification or research experience). The PI must have a contract of employment that will last for at least the duration of the grant requested, or be able to show evidence that their current contract would be extended if the grant were awarded.
A research group can only submit a single application to Worldwide Cancer Research in a grant round. For example, if you are the PI on an application in this round, no member of your research group can be PI on a second application. You can be PI on one application and a co-applicant or collaborator on other applications at the same time. If the principal investigator on an application is successful in a grant round, they cannot submit an application in the next grant round.
Other senior researchers who would be substantially involved in managing the project can be included as co-applicants. Co-applicants should be at senior post-doctoral level or above (i.e. with greater than 3-years post-doctoral research experience). Co-applicants do not need to be at the same institution as the PI. Individual scientists from commercial organisations can be named as collaborators if they would provide specific expertise or reagents to the project. The nature of their involvement must be made clear. Scientists from commercial organisations cannot be co-applicants.
Commercial, for-profit organizations e.g. biotechnology and pharmaceutical companies cannot apply for a grant. Neither is it permitted for a research institution to transfer Worldwide Cancer Research grant funds to a commercial organisation except for payment for specific services, items and reagents used in the project. This includes transferring money to spin-out companies from the laboratory or institute.
The Foundation does not support clinical research, including clinical trials, patient care, nursing or healthcare delivery research. They also do not support other types of applied cancer research such as policy, public health or psychosocial research. Proposals that contain a small clinical element as an essential part of a basic or translational research project are often permitted, but you are advised to contact the funding source for advice before submitting your proposal.
The Foundation will not fund animal research projects in countries or institutions that do not in our view have sufficient controls on laboratory animal welfare. For further details see the animal research policy at the end of the attached handbook.
Clinical costs cannot be charged to a Worldwide Cancer Research grant. This includes the costs of patient or volunteer recruitment. Applications will not be accepted that contain budget items such as patient expenses, the salaries of purely clinical staff such as research nurses, or honorariums or consultancy fees for clinical collaborators. It is also not acceptable to include costs for the clinical investigation, diagnosis or follow-up of patients involved in the research study.
For additional information about ineligible expenses, see:
The April 2019 grant round opened on Friday 22 March 2019. Completed applications can only be submitted during the submission period, Thursday April 4, until Friday, May 3, 2019. Worldwide Cancer Research will only accept the first 500 applications submitted in the grant round. Applications must be submitted by 5:00 PM (British Local Time) on Friday May 3, 2019.
If your institution does not appear in the drop-down list as part of the registration process, please contact Worldwide Cancer Research providing details of your institution and proof of the nonprofit status of the organization so that it can be added to the database.
The approval of the submission by the Head of Department and Authorizing Officer is the final step in the application process. After the PI clicks the Submit button, the Head of Department has to approve the submission and then the Authorizing Officer has to approve it, in that order. It is only after they have both done this that the application is actually submitted. This must happen before the application deadline. the funding source will not extend the deadline to allow this approval to be made.
It takes approximately 9-12 months from the submission of a grant application until the start of funding for successful applications.
For more information:
How to apply online: https://www.worldwidecancerresearch.org/funding-for-research/make-an-application/
Research strategy: https://www.worldwidecancerresearch.org/who-we-are/our-research-strategy/
Application procedure: https://www.worldwidecancerresearch.org/funding-for-research/application-handling-procedure/
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
Dr. Helen Rippon, Chief Executive
Worldwide Cancer Research
Madras House, St Andrews
Fife, Scotland, KY16 9EH
Phone: 0300 777 7910
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
USA Territories: American Samoa (USA) Guam (USA) Puerto Rico (USA) Virgin Islands (USA) Northern Mariana Islands (USA)
USA Compact Free Associations: The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA)
Canada: Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon
International country outside of the USA, Israel and Canada.